U.S. markets open in 8 hours 20 minutes

DIAGNOS Inc. (ADK.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.5600+0.0200 (+3.70%)
At close: 3:52PM EDT
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.5400
Open0.5500
Bid0.5500 x 0
Ask0.5700 x 0
Day's Range0.5500 - 0.5700
52 Week Range0.1400 - 0.7700
Volume29,200
Avg. Volume106,077
Market Cap37.69M
Beta (5Y Monthly)0.32
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    All
    News
    • DIAGNOS Announces a Pilot with Opticalia in Spain
      GlobeNewswire

      DIAGNOS Announces a Pilot with Opticalia in Spain

      BROSSARD, Quebec, July 28, 2021 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Company”) (TSX Venture: ADK) (OTCQB: DGNOF) (FRA: 4D4A), a leader in early detection of critical health issues, announces today the signing of a pilot in Spain with three franchisees from Opticalia Group. “A proposal that combines optometrist knowledge, telemedicine and artificial intelligence to obtain fast results, without invasive methodology and with totally reliable results. A smart retinography is also used

    • DIAGNOS Announces the Official Opening of the AI Assisted Screening Clinic at Magrabi Hospital with the Presence of the Undersecretary of the Ministry of Health of Saudi Arabia
      GlobeNewswire

      DIAGNOS Announces the Official Opening of the AI Assisted Screening Clinic at Magrabi Hospital with the Presence of the Undersecretary of the Ministry of Health of Saudi Arabia

      Magrabi Hospital Magrabi Hospitals launches initiative for early screening for diabetic retinopathy BROSSARD, Quebec, July 22, 2021 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Company”) (TSX Venture: ADK) (OTCQB: DGNOF) (FRA: 4D4A), a leader in early detection of critical health issues, is pleased to announce the official opening of the initial clinics at the Magrabi Hospital. Dr. Ibrahim Al-Omar, Undersecretary of the Ministry of Health for Investment, inaugurated last Wednesday the ear

    • DIAGNOS initiates a clinical trial study in the USA for early detection and prevention of Stroke using its new application CARA-STROKE
      GlobeNewswire

      DIAGNOS initiates a clinical trial study in the USA for early detection and prevention of Stroke using its new application CARA-STROKE

      BROSSARD, Quebec, July 20, 2021 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Company”) (TSX Venture: ADK) (OTCQB: DGNOF), a leader in early detection of critical health issues, announces today the initiation of a clinical trial study with CommonSpirit Health Research Institute, Chattanooga Center for Neurologic Research LLC and conducted at the CommonSpirit Hospital in Chattanooga, to confirm early Proof-of-Concept results that showed a strong potential in the early detection of stroke th